Detalles de la búsqueda
1.
Therapeutic use of granulocyte colony-stimulating factor (G-CSF) in patients with febrile neutropenia: a comprehensive systematic review for clinical practice guidelines for the use of G-CSF 2022 from the Japan Society of Clinical Oncology.
Int J Clin Oncol;
2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38696053
2.
Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.
Int J Clin Oncol;
2024 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38649648
3.
Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology.
Int J Clin Oncol;
2024 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38578596
4.
Effectiveness and safety of primary prophylaxis of granulocyte colony-stimulating factor during dose-dense chemotherapy for urothelial cancer: Clinical Practice Guidelines for the Use of G-CSF 2022.
Int J Clin Oncol;
29(5): 545-550, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38517658
5.
Effectiveness and safety of primary prophylaxis with G-CSF after induction therapy for acute myeloid leukemia: a systematic review and meta-analysis of the clinical practice guidelines for the use of G-CSF 2022 from the Japan society of clinical oncology.
Int J Clin Oncol;
29(5): 535-544, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38494578
6.
Optimal timing of prophylactic pegylated G-CSF after chemotherapy administration for patients with cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.
Int J Clin Oncol;
29(5): 551-558, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38526621
7.
Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of G-CSF 2022.
Int J Clin Oncol;
29(5): 559-563, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38538963
8.
Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022.
Int J Clin Oncol;
29(4): 355-362, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38353907
9.
Phase II study of gemcitabine, cisplatin, and bevacizumab for first recurrent and refractory ovarian clear cell carcinoma Kansai Clinical Oncology Group-G1601.
Anticancer Drugs;
34(7): 857-865, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36729915
10.
Clinicopathological features and programmed death-ligand 1 immunohistochemical expression in a multicenter cohort of uterine and ovarian melanomas: a retrospective study in Japan (KCOG-G1701s).
Melanoma Res;
32(3): 150-158, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35377861
11.
Paraneoplastic AQP4-IgG-Seropositive Neuromyelitis Optica Spectrum Disorder Associated With Teratoma: A Case Report and Literature Review.
Neurol Neuroimmunol Neuroinflamm;
8(5)2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34285095
12.
Correlation of World Health Organization 2010 Classification for Gastroenteropancreatic Neuroendocrine Neoplasms with the Prognosis of Ovarian Neuroendocrine Neoplasms: Kansai Clinical Oncology Group-Protocol Review Committee/Intergroup Study.
Neuroendocrinology;
111(4): 320-329, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-32097950
13.
Randomized phase III trial comparing pegylated liposomal doxorubicin (PLD) at 50 mg/m² versus 40 mg/m² in patients with platinum-refractory and -resistant ovarian carcinoma: the JGOG 3018 Trial.
J Gynecol Oncol;
32(1): e9, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33185050
14.
Clinical status and prognostic factors in Japanese patients with uterine leiomyosarcoma.
Gynecol Oncol;
157(1): 115-120, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31983515
15.
Clinicopathologic features, treatment, prognosis and prognostic factors of neuroendocrine carcinoma of the endometrium: a retrospective analysis of 42 cases from the Kansai Clinical Oncology Group/Intergroup study in Japan.
J Gynecol Oncol;
30(6): e103, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31576694
16.
Multi-institutional phase II study of neoadjuvant irinotecan and nedaplatin followed by radical hysterectomy and the adjuvant chemotherapy for locally advanced, bulky uterine cervical cancer: A Kansai Clinical Oncology Group study (KCOG-G1201).
J Obstet Gynaecol Res;
45(3): 671-678, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30575239
17.
Association of CXC chemokine receptor type 4 expression and clinicopathologic features in human vulvar cancer.
Int J Gynecol Cancer;
23(6): 1111-7, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23765204
18.
Large or persistent lymphocyst increases the risk of lymphedema, lymphangitis, and deep vein thrombosis after retroperitoneal lymphadenectomy for gynecologic malignancy.
Arch Gynecol Obstet;
288(3): 587-93, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23455541
19.
Torsion of a hydrosalpinx in a virgin patient with Mayer-Rokitansky-Küster-Hauser syndrome: report of a rare condition and its possible etiology.
J Pediatr Adolesc Gynecol;
26(2): e37-8, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23317578
20.
Preoperative management of patients with gynecologic malignancy complicated by existing venous thromboembolism.
Eur J Obstet Gynecol Reprod Biol;
164(1): 85-8, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22672994